Introduction
Vascular endothelial growth factor (VEGF) is a principal regulator of vasculogenesis and angiogenesis (Ferrara and Davis-Smyth, 1997) . VEGF binds to two receptor-type tyrosine kinases, Flt-1 (VEGF receptor-1) (Shibuya et al., 1990; de Vries et al., 1992) and KDR/ Flk-1 (VEGF receptor-2) (Quinn et al., 1993) , and to membrane protein neuropilin-1, which does not contain a tyrosine kinase domain (Soker et al., 1998) . Flt-1 and KDR/Flk-1 have seven immunoglobulin-like repeats in the extracellular domain, a single transmembrane region, and a tyrosine kinase domain in the intracellular domain that is interrupted by a kinaseinsert domain. Flt-1 has a higher anity with K d of approximately 10 ± 20 pmol/L (de Vries et al., 1992) , while the K d of KDR is approximately 75 ± 125 pmol/L (Terman et al., 1992) . Although neuropilin-1 lacks the signaling domain within its molecule, it may enhance the eects of VEGF by transferring VEGF to the tyrosine kinase receptors (Soker et al., 1998) .
Flt-1 and KDR/Flk-1 have distinct functions in vascular development in embryos. Flk-1 knockout mice, which die by embryonic day 8.5 (E8.5), lack both ECs and hematopoietic cells (Shalaby et al., 1995) . Indeed, KDR is shown to be a key marker de®ning hematopoietic stem cells in human postnatal hematopoietic tissue (Ziegler et al., 1999) . In contrast, Flt-1 knockout mice, which also die around E8.5, have abundant ECs, which do not assemble in functional vessels (Fong et al., 1995) . In spite of these observations, properties of KDR/Flk-1 and Flt-1 in normally dierentiated ECs are controversial. It has been reported that KDR but not Flt-1 plays a principal role in the transduction of VEGF-mediated eects in porcine aortic ECs lacking endogenous VEGF receptors which are transfected with either Flt-1 or KDR gene (Waltenberger et al., 1994; Kroll et al., 1997) . The importance of KDR/Flk-1 is further emphasized by using mutant VEGF which only binds to KDR (Keyt et al., 1996) or KDR antisense oligonucleotides (Bernatchez et al., 1999) . However, Flt-1 does play a role in VEGF-stimulated migration of monocytes/ macrophages which express only Flt-1 (Shen et al., 1993; Barleon et al., 1996; Clauss et al., 1996) .
In the present study, we investigated the roles of two VEGF receptors by using newly developed blocking monoclonal antibodies (mAbs). Our results indicate that the Flt-1-mediated signal elicits migration of HUVECs by actin reorganization. A distinct signal is generated by the KDR. This signal in¯uences cell migration by regulating phosphorylation of focal adhesion kinase (FAK) and paxillin and the assembly of vinculin in focal adhesion plaque. Moreover, this latter signal regulates DNA synthesis.
showed that KDR (230 kDa) and Flt-1 (210 kDa) were tyrosine-phosphorylated by the treatment of HUVECs with VEGF ( Figure 2a ). Placenta growth factor (PlGF) only binds to Flt-1 (Park et al., 1994) . PlGF tyrosinephosphorylated Flt-1 but not KDR (Figure 2b ). KM1750 at 1 mg/ml completely inhibited tyrosine phosphorylation of 210 kDa protein (Figure 2b ). KM1992 inhibited tyrosine phosphorylation of 230 kDa protein in a dose-dependent manner, partially at 10 mg/ml and completely at 30 mg/ml (Figure 2b ). By using these two mAbs, we evaluated the roles of Flt-1 and KDR in the transduction of VEGF-mediated signals in HUVECs.
VEGF stimulated DNA synthesis of HUVECs, with the maximal stimulation being observed at 50 ng/ml (Figure 3a) . KM1992 inhibited VEGF-stimulated DNA synthesis partially (10 mg/ml) or completely (30 mg/ml), whereas KM1750 exhibited no inhibition at 1 mg/ml (Figure 3b ). Equivalent concentration of PlGF (1 nM) did not augment DNA synthesis of HUVECs ( Figure  3c ). Interestingly, the combination of KM1750 (1 mg/ ml) and KM1992 (10 mg/ml) almost completely inhibited VEGF-stimulated DNA synthesis ( Figure   3b ). This combined eect of KM1750 and KM1992 might suggest KDR/Flt-1 heterodimerization. However, we could not reproducibly point out KDR/Flt-1 heterodimerization.
VEGF stimulated migration of HUVECs. The maximal stimulation observed at 10 ng/ml with a typical bell-shaped curve (Figure 4a ). In contrast to DNA synthesis, 1 mg/ml of KM1750 completely inhibited VEGF-stimulated migration of HUVECs, whereas KM1992 (up to 30 mg/ml) showed 50% inhibition ( Figure 4b ). Equivalent concentration of PlGF (0.2 nM) stimulated migration of HUVECs, however it was not as potent as VEGF (Figure 4c ). The eect of KM1750 observed in this assay was not in¯uenced by cell proliferation, since the same concentration of KM1750 had no eect on DNA synthesis of HUVECs (Figure 3b) .
Cell migration is a complex phenomenon which requires cytoskeleton-regulated cell motility and cell adhesion (Lauenburger and Horwitz, 1996) . VEGF elicited actin reorganization and vinculin assembly in focal adhesion plaque of HUVECs ( Figure 5 ). One mg/ ml of KM1750 completely abrogated actin reorganiza- tion, but failed to aect vinculin assembly ( Figure 5 ). PlGF elicited actin reorganization but not vinculin assembly ( Figure 5 ). Conversely, KM1992 inhibited vinculin assembly partially (10 mg/ml) or completely (30 mg/ml), but failed to aect actin reorganization even at 30 mg/ml ( Figure 5 ). Therefore, Flt-1 regulates actin reorganization, whereas KDR regulates vinculin assembly.
Cell spreading correlates with F-actin formation (Lewis et al., 1996) . VEGF stimulated spreading of HUVECs ( Figure 6 ). One mg/ml of KM1750 completely abrogated this eect of VEGF, whereas 30 mg/ml of KM1992 did not. Vinculin assembly in focal adhesion plaque is correlated with tyrosine phosphorylation of FAK and paxillin (Gumbiner, 1996) . VEGF induced tyrosine phosphorylation of FAK and paxillin ( Figure 7 ). KM1750 exhibited no eect on phosphorylation of FAK or paxillin, whereas 30 mg/ml of KM1992 completely inhibited phosphorylation of FAK and paxillin (Figure 7) .
The intracellular signal transduction of Flt-1 and KDR was further evaluated. VEGF activated MAP kinases, i.e., ERK1/2 and p38 MAP kinase in HUVECs (Figure 8 ). The activation of ERK1/2 was completely inhibited by anti-KDR mAb (30 mg/ml), whereas anti-Flt-1 mAb (1 mg/ml) exhibited no inhibition ( Figure 8 ). In contrast, the activation of p38 MAP kinase was completely abrogated by anti-Flt-1 mAb (1 mg/ml), whereas anti-KDR mAb exhibited no inhibition ( 
Discussion
Here we examined the role of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF eects by newly developed blocking monoclonal antibodies. Figure 11 summarizes the ®ndings of the present study. Although the blocking anti-KDR mAb has been reported (Zhu et al., 1998) , the blocking antiFlt-1 mAb is the ®rst to be described. KDR is reported to play a principal role in the signal transduction of VEGF eects, and the participation of Flt-1 in ECs is controversial (Waltenberger et al., 1994; Kroll et al., 1997) . Our present results clearly indicate that both Flt-1 and KDR play roles in the signal transduction of VEGF in normally dierentiated human ECs, and the roles of these two receptors are distinct.
Anti-KDR mAb but not anti-Flt-1 mAb completely inhibited the stimulatory eect of VEGF on DNA synthesis. This result is in good agreement with Regulation of actin reorganization by Flt-1 and vinculin assembly to focal adhesion plaque by KDR. HUVECs were plated on type-I collagen coated dishes in M-199 containing 5% FCS, and were incubated for 2 h at 378C. Thereafter, HUVECs were left untreated or exposed to indicated concentrations of KM1750 (aFlt-1 mAb) and/or KM1992 (aKDR mAb) for 15 min. Ten ng/ml of VEGF was added to the cultures, which were further incubated for 15 min. After the incubation, cells were ®xed and analysed previous reports (Waltenberger et al., 1994; Keyt et al., 1996; Kroll et al., 1997; Bernatchez et al., 1999) , and further con®rms that VEGF stimulates DNA synthesis of ECs preferentially via KDR. KDR-mediated signal preferentially modulates DNA synthesis of HUVECs via the activation of ERK1/2. It is generally accepted that the activation of ERK1/2 is required for DNA synthesis (Rousseau et al., 1977; Dudley et al., 1995) . This eect of ERK1/2 is thought to be mediated via the induction of cyclin D1 (Weber et al., 1997) . In contrast to DNA synthesis, the regulation of cell migration by VEGF appears to be more complicated. The most important ®ndings in our present experiments are that cytoskeleton-regulated cell motility and cell adhesion on cell migration are regulated by distinct receptor systems.
Our results indicate that Flt-1-mediated signal preferentially modulates actin reorganization of HUVECs via the activation of p38 MAP kinase. This is in good agreement with previous report that VEGF activates p38 MAK kinase in HUVECs and transduces the signal for cell migration (Rousseau et al., 1997) . Actin reorganization is essential for cell motility (Lauenburger and Horwitz, 1996) , thus the blockade of Flt-1-mediated signals completely stopped migration of HUVECs. The mechanism by which p38 MAK kinase modulates actin reorganization in response to VEGF remains to be elucidated. The best characterized molecules, which are essential for actin reorganization and cell motility, are rho family low molecular weight G proteins including rac, CDC44, and rho A (Hall, 1998) . We are currently examining whether rho family low molecular weight G proteins participate in the signal transduction of Flt-1 and p38 MAK kinase.
The cell adhesion-related molecules such as FAK and paxillin are generally activated by two systems, namely, growth factor and integrin (Craig and Johnson, 1996) . Regarding growth factor-mediated regulation in Swiss3T3 cells, tyrosine phosphorylation of growth factor receptor is followed by subsequent tyrosine phosphorylation of FAK and paxillin, and recruitment of talin and vinculin to focal adhesion plaque (Abedi and Zachary, 1997) . Thus, VEGFmediated system in HUVECs may be comparable to that in Swiss3T3 cells, and this system is preferentially mediated by KDR. However, ERK1/2 may not play a major role in this system, since speci®c inhibition of ERK1/2 by PD98059 exhibited only a marginal eect on vinculin assembly and phosphorylation of FAK and paxillin. Previous reports indicate that VEGF, by binding to KDR, activates ERK1/2 via a phospholipase Cg (PLCg)-PKC-dependent pathway (Seetharam et al., 1995; Guo et al., 1995; Takahashi and Shibuya, 1997) . We observed that speci®c inhibition of PKC by GF109203X completely abrogated vinculin assembly as well as DNA sysnthesis. It has been reported that activation of PKC regulates phosphorylation of FAK and paxillin in ECs as well as other cell types (Abedi and Zachary, 1997; Lewis et al., 1996; Slack, 1998) . Taken together, phosphorylation of FAK and paxillin and the assembly of vinculin were regulated preferentially via a PKC-dependent and ERK1/2-independent pathway, while DNA synthesis was regulated via a PKC-dependent and ERK1/2-dependent pathway.
Our present study clearly indicates that Flt-1 does participate in the signal transduction of VEGF eects in normally dierentiated human ECs. However, Flt-1 lacking the tyrosine kinase domain has recently been Figure 6 Regulation of cell spreading by Flt-1. After the ®xation of HUVECs as described in Figure 5 , cell size was analysed with NIH image analyzer soft Figure 7 Tyrosine phosphorylation of FAK and paxillin by KDR. HUVECs were pretreated with 0.1 mmol/L of sodium orthovanadate for 1 h, and were left untreated or exposed to indicated concentrations of KM1750 (aFlt-1 mAb) and/or KM1992 (aKDR mAb) 15 min prior to the addition of VEGF. Then the cultures were incubated with or without 10 ng/ml of VEGF for 15 min. Immunoprecipitation followed by Western blotting was performed. IP: antibodies used for immunoprecipitation, IB: antibodies used for Western blotting Figure 8 Activation of ERK1/2 was mediated via KDR, whereas that of p38 was mediated via Flt-1. HUVECs were left untreated or exposed to indicated concentrations of KM1750 (aFlt-1 mAb) and/or KM1992 (aKDR mAb) 15 min prior to the addition of VEGF. Then the cultures were incubated with or without 10 ng/ml of VEGF for 5 min. Activation of ERK1/2 or p38 was determined by immunoblotting with anti-dually phosphorylated ERK1/2 antibody (ap-ERK1/2) or anti-dually phosphorylated p38 antibody (ap-p38) shown to be sucient for the normal development of vasculature in the murine embryo (Hiratsuka et al., 1998) . This discrepancy raises several questions. Is kinase negative Flt-1 really negative in terms of the signal transduction? The signal transduction systems of ECs in those mice expressing tyrosine kinase negative Flt-1 need to be determined. It is possible that some other signaling molecules may associate with tyrosine kinase negative Flt-1. Alternately, the role of Flt-1 in ECs of developing vasculature in embryo and in dierentiated ECs of postnatal state or of adult may not be identical. In any case, our present results provide important information for understanding the function of two VEGF receptors in human dierentiated ECs. HUVECs on 35 mm type-I collagen coated dishes were left untreated or exposed to SB203580 (3 mM), PD98059 (25 mM), or GF109203X (3 mM) for 60 min prior to the addition of VEGF. The cultures were wounded with a razor blade. (c) HUVECs were pretreated with 0.1 mM of sodium orthovanadate for 1 h, and were left untreated or exposed to SB203580 (3 mM) or PD98059 (25 mM) for 60 min prior to the addition of VEGF. Thereafter the cultures were incubated with or without 10 ng/ml of VEGF for 15 min. Immunoprecipitation followed by Western blotting was performed. IP: antibodies used for immunoprecipitation, IB: antibodies used for Western blotting. Activation of ERK1/2 or p38 MAP kinase was determined by Western blotting with antidually phosphorylated ERK1/2 Ab (ap-ERK1/2) or anti-dually phosphorylated p38 MAP kinase Ab (ap-p38). (Minneapolis, MN, USA) . Human VEGF 165 was synthesized with the baculovirus/insect cell system as previously described (Sawano et al., 1996) . Figure 10 VEGF-mediated phosphorylation of FAK and paxillin was mediated via a PKC-dependent and ERK1/2-independent pathway. HUVECs were plated and incubated for 2 h at 378C on type-I collagen coated dishes (35 mm) in M-199 containing 5% FCS without any supplements. HUVECs were left untreated or exposed to SB203580 (3 mM), PD98059 (25 mM), or GF109203X (3 mM) for 60 min. Thereafter, VEGF (10 ng/ml) was added to the cultures, which were incubated for 15 min. After the incubation, cells were ®xed and analysed Figure 11 The intracellular signal transduction of VEGF-mediated eects in HUVECs. KDR mediates the signals for DNA synthesis, phosphorylation of FAK and paxillin, and vinculin assembly. The signals for DNA synthesis is mediated via PKCdependent and ERK1/2 dependent pathway, whereas those for phosphorylation of FAK and paxillin and vinculin assembly are preferentially mediated via PKC-dependent and ERK1/2-independent pathway. Flt-1 activates p38 MAP kinase, and activated p38 regulates cell migration via actin reorganization Roles of KDR and Flt-1 in the signal transduction S Kanno et al
Materials and methods

Materials
Cell culture
HUVECs were obtained from KURABO (Osaka, Japan) and routinely cultured on type-I collagen coated dishes in endothelial basal medium containing endothelial cell growth supplements (Clonetics Corp., Walkersville, MD, USA) and 5% FCS (Summit Biotechnology, Ft. Collins, CO, USA). Prior to the following experiments, HUVECs were preincubated overnight (confocal microscopy experiment) or for 24 h (the other experiments) in M-199 (Nissui Pharmaceutical Co., Ltd. Tokyo, Japan) containing 5% FCS in the absence of growth supplements. Flt-1 overexpressing NIH3T3 cells (NIH3T3-Flt-1), KDR overexpressing NIH3T3 cells (NIH3T3-KDR) and NIH3T3 control transfectant cells (NIH3T3-neo) established by Sawano et al. (1996) were cultured in DMEM containing 200 mg/ml G418 and 10% FCS (Nissui, Tokyo, Japan).
Anti-VEGF receptors mAbs
Soluble VEGF receptor proteins, Flt-1 7N carrying the Nterminal 1st to 7th and Flt-1 3N carrying 1st to 3rd Ig-like domains of Flt-1, were obtained as described previously (Tanaka et al., 1997) . KDR 7N carrying the N-terminal 1st to 7th Ig-like domains and KDR 5 d 1N carrying the 2nd to 5th Ig-like domains of KDR fused with the Fc portion of an IgG (KDR 7N-Fc and KDR 5 d 1N-Fc, respectively) were obtained as described previously (Shinkai et al., 1998) . The production of anti-human Flt-1 mAbs including KM1750 (mouse IgG2b) and anti-human KDR mAbs including KM1992 (mouse IgG1) will be described elsewhere (M Ito et al., in preparation) . Brie¯y, B3C3F1 mice (Charles River Japan, Kanagawa, Japan) at 6 ± 8-weeks-old were immunized by i.p. injection of Flt-1 7N or KDR 5 d 1N-Fc. Spleen cells were fused with mouse myeloma cells and hybridoma cells producing the mAbs to Flt-1 3N and KDR 7N-Fc, were selected.
Elisa ELISA was performed as described previously (Hanai et al., 1986) . Brie¯y, 96-well immunoplates (Greiner, Frickenhausen, Germany) were coated with 50 ml/well of Flt-1 7N or KDR 7N-Fc (2 mg/ml in PBS) for overnight at 48C, and were blocked with 1% BSA in PBS. Fifty ml of anti-VEGF receptors mAbs were added to each well and incubated at room temperature for 2 h. After washing three times with 0.05 % Tween-20 in PBS, 50 ml of peroxidase-labeled rabbit anti-mouse immunoglobulin (Dakopatts, Glosrup, Denmark) were allowed to react for 2 h at room temperature. After washing six times with 0.05% Tween-20 in PBS, 50 ml of 1 mmol/L 2,2-azinobis (3-ethyl benzothiazoline-6-sulfonic acid) diammonium solution were added to each well and incubated at room temperature for 15 min. The reaction was stopped with 5% sodium dodecyl sulfate solution and the absorbance at 415 nm was measured by microtiter plate analyzer (E-max, Molecular Devices, Menlo Park, CA, USA).
Flow-cytometric analysis
Biotinylation of mAb was performed as described (Shitara et al., 1987) . In indirect immuno¯uorescence, the cells (1610   6   ) were incubated with biotinylated mAbs (30 mg/ml) for 30 min at 48C. After the reaction with 5 mg/ml Streptoavidin-RPhycoerythrin (Gibco, Gaithersburg, MD, USA), the reactivity was analysed in an EPICS Elite¯ow cytometer (Coulter Corporation, Hialeah, FL, USA).
DNA synthesis
Ten thousand HUVECs preincubated for 24 h in M-199 containing 5% FCS were incubated with indicated concetration of VEGF and 1.0 mCi [methyl 3 H]thymidine for another 24 h. Incorporation of [methyl 3 H]thymidine into cells was determined by liquid scintigraphy. For the blocking experiments, indicated concentrations of antibodies or inhibitors were added to the culture 15 min prior to the addition of VEGF (50 ng/ml).
Wound migration assay
Con¯uent monolayers of HUVECs on 35 mm type-I collagen coated dishes were wounded with a razor blade as described (Sato and Rifkin, 1988) , and incubated for 24 h with or without indicated concentrations of VEGF. After the incubation, cells that had migrated across the edge of the wound were counted. For the blocking experiments, indicated concentrations of antibodies or inhibitors were added to the culture 15 min prior to the addition of VEGF (10 ng/ml).
Western blot analysis
For Western blotting of Flt-1 and KDR, HUVECs were cultured in M-199 containing 5% FCS and not treated with VEGF. For the blocking experiments, antibodies or inhibitors were added to HUVECs 15 min prior to the addition of VEGF. Thereafter, 10 ng/ml of VEGF was added to the cultures, which were incubated for 15 min. Cells were washed with PBS, collected in modi®ed RIPA buer (2 mmol/L sodium orthovanadate, 50 mmol/L NaF, 20 mmol/L HEPES, 150 mmol/L NaCl, 1.5 mmol/L MgCl 2 , 5 mmol/L sodium pyrophosphate, 10% glycerol, 0.2% Triton X-100, 5 mmol/L EDTA, 1 mmol/L PMSF, 10 mg/ml leupeptin, and 10 mg/ml aprotinin), and allowed to lyse for 30 min on ice. Samples were clari®ed by centrifugation for 15 min at 15 000 r.p.m. at 48C. Western blotting was performed as described previously (Iwasaka et al., 1996) . Brie¯y, the samples containing equal amounts of protein were separated on SDS polyacrylamide gel under reducing conditions and transferred to nitrocellulose membranes. The blots were incubated for 1 h at room temperature with the indicated primary antibodies, followed by incubation for 1 h with horseradish peroxidase-conjugated protein G. Immunoreactive bands were visualized by chemiluminescence with a LAS-1000 Image Analyzer (Fuji, Tokyo, Japan).
Immunoprecipitation followed by Western blot analysis
HUVECs cultured in M-199 containing 5% FCS were preincubated with 0.1 mmol/L of sodium orthovanadate for 1 h. Then, antibodies or inhibitors were added to the cultures 15 min prior to the addition of VEGF. Thereafter, HUVECs were incubated with 10 ng/ml of VEGF for 15 min (for FAK, paxillin) or 5 min (for Flt-1 and KDR). Samples were prepared as mentioned in Western blot analysis and incubated with the indicated antibodies and protein ASepharose for 24 h at 48C. The immunoprecipitates were washed four times in modi®ed RIPA buer, boiled for 5 min in reducing buer, and electrophoresed on SDS polyacrylamide gels; Western blotting was then performed.
Actin reorganization and vinculin assembly
HUVECs on type-I collagen coated dishes (3610 4 cells/ 35 mm dish) were incubated for 2 h at 378C in M199 containing 5% FCS, and further incubated with or without KM1750 and/or KM1992 for 15 min at 378C. In some experiments, cells were preincubated with PD98059 (25 mM), SB203580 (3 mM), GF109203X (3 mM), or wortmannin (100 nM) for 60 min. Thereafter, 10 ng/ml of VEGF was added to the cultures, which were further incubated for 15 min. After the incubation, cells were ®xed with 3.7% formaldehyde and permeabilized with 0.1% NP40 in PBS. Non-speci®c binding sites were blocked with 1% BSA and 10% skim milk in PBS. F-actin was detected with rhodamineconjugated phalloidin. Vinculin was detected by indirect immuno¯uorescence using monoclonal anti-vinculin antibody and FITC-labeled secondary antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). The cells were observed with a confocal microscope (LSM410) (Carl Zeiss Jena GmbH, Jena, Germany). Cell size was analysed with NIH Image Analyzer soft.
